BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1131 related articles for article (PubMed ID: 12097282)

  • 21. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism.
    Potapova O; Fakhrai H; Mercola D
    Int J Cancer; 1996 May; 66(5):669-77. PubMed ID: 8647631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.
    Alexandru O; Sevastre AS; Castro J; Artene SA; Tache DE; Purcaru OS; Sfredel V; Tataranu LG; Dricu A
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR).
    Baudhuin LM; Jiang Y; Zaslavsky A; Ishii I; Chun J; Xu Y
    FASEB J; 2004 Feb; 18(2):341-3. PubMed ID: 14657000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
    Potapova O; Fakhrai H; Baird S; Mercola D
    Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PDGF-D, a new protease-activated growth factor.
    LaRochelle WJ; Jeffers M; McDonald WF; Chillakuru RA; Giese NA; Lokker NA; Sullivan C; Boldog FL; Yang M; Vernet C; Burgess CE; Fernandes E; Deegler LL; Rittman B; Shimkets J; Shimkets RA; Rothberg JM; Lichenstein HS
    Nat Cell Biol; 2001 May; 3(5):517-21. PubMed ID: 11331882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
    Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
    Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
    Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ
    J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-derived growth factor (PDGF) receptor-alpha-activated c-Jun NH2-terminal kinase-1 is critical for PDGF-induced p21WAF1/CIP1 promoter activity independent of p53.
    Yu J; Liu XW; Kim HR
    J Biol Chem; 2003 Dec; 278(49):49582-8. PubMed ID: 14506245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells.
    Uhrbom L; Hesselager G; Ostman A; Nistér M; Westermark B
    Int J Cancer; 2000 Feb; 85(3):398-406. PubMed ID: 10652433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.
    Najy AJ; Won JJ; Movilla LS; Kim HR
    Mol Cancer Res; 2012 Aug; 10(8):1087-97. PubMed ID: 22689130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-Src couples PI 3 kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells.
    Choudhury GG; Mahimainathan L; Das F; Venkatesan B; Ghosh-Choudhury N
    Cell Signal; 2006 Nov; 18(11):1854-64. PubMed ID: 16530387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.
    Roberts WG; Whalen PM; Soderstrom E; Moraski G; Lyssikatos JP; Wang HF; Cooper B; Baker DA; Savage D; Dalvie D; Atherton JA; Ralston S; Szewc R; Kath JC; Lin J; Soderstrom C; Tkalcevic G; Cohen BD; Pollack V; Barth W; Hungerford W; Ung E
    Cancer Res; 2005 Feb; 65(3):957-66. PubMed ID: 15705896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB.
    Li XA; Bianchi C; Sellke FW
    J Surg Res; 2001 Oct; 100(2):197-204. PubMed ID: 11592793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell adhesion regulates platelet-derived growth factor-induced MAP kinase and PI-3 kinase activation in stellate cells.
    Carloni V; Defranco RM; Caligiuri A; Gentilini A; Sciammetta SC; Baldi E; Lottini B; Gentilini P; Pinzani M
    Hepatology; 2002 Sep; 36(3):582-91. PubMed ID: 12198650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells.
    Johnson MD; Okedli E; Woodard A; Toms SA; Allen GS
    J Neurosurg; 2002 Sep; 97(3):668-75. PubMed ID: 12296652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
    Watanabe T; Ohtani T; Aihara M; Ishiuchi S
    J Neurosurg; 2013 Apr; 118(4):838-45. PubMed ID: 23311938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imatinib mesylate stimulates low-density lipoprotein receptor-related protein 1-mediated ERK phosphorylation in insulin-producing cells.
    Fred RG; Boddeti SK; Lundberg M; Welsh N
    Clin Sci (Lond); 2015 Jan; 128(1):17-28. PubMed ID: 24865476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-derived growth factor (PDGF) receptor-alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta -induced phenotypic transformation.
    Yu J; Deuel TF; Kim HR
    J Biol Chem; 2000 Jun; 275(25):19076-82. PubMed ID: 10777515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle.
    Fang L; Yan Y; Komuves LG; Yonkovich S; Sullivan CM; Stringer B; Galbraith S; Lokker NA; Hwang SS; Nurden P; Phillips DR; Giese NA
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):787-92. PubMed ID: 15061151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.